Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 230 participants.
Also called NCT06632834
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 230 participants
- Registry
-
NCT06632834
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Taiwan
- Registry status
- Unknown status
Technical summary
Registry record NCT06632834. Allocation not applicable; no masking; primary purpose treatment. Start 2020-08-15 (actual); primary completion 2025-01-19 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Outcome-targeted Therapy: Principle and Outcome Evaluation: Clinical Study and Phenotype-genotype Correlation
- Condition
- Dilated Cardiomyopathy
- Intervention (Drug)
- simvastatin therapy
- Lead sponsor
- National Taiwan University Hospital
Record details
- Record id
cardio:ct-nct06632834- Content hash
f53bf742131d691cea2e81479d30097abc2f85caae4d1660d8de47881b61f655